Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HUMA
#3816
Humacyte, Inc. Common Stock
0.6
9
USD
+2.99%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.99%
Monthly Change
-41.03%
6 month change
-61.67%
Year Change
-53.38%
Previous Close
0.6
7
Open
0.6
9
Bid
Ask
Low
0.6
9
High
0.6
9
Volume
88
Markets
US Stock Market
Healthcare
HUMA
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.86 M
103 M
103.33 M
119.08 M
155.12 M
222.02 M
—
Valuation ratios
Enterprise value
—
560.01 M
98.93 M
302.94 M
802.35 M
198.2 M
1.15 B
Price to earnings ratio
—
-10.98
-17.58
-2.7
-4.01
-3.69
-18.37
Price to sales ratio
—
229.44
138.94
—
-149.58 K
74.54
1 029.6
Price to cash flow ratio
—
-3.57
-3.06
-4.08
-6.1
-1.45
-8.43
Price to book ratio
—
2.37
1.86
22.06
-11.36
48.86
34.03
Enterprise value to EBITDA ratio
—
-7.35
-0.91
-2.87
-6.89
-14.49
-22.24
Profitability ratios
Return on assets %
—
-0.09
-0.06
-0.86
-1.08
-0.35
-0.44
Return on equity %
—
-0.22
-0.1
-8.18
2.82
-13.13
-12.5
Return on invested capital %
—
-406.93
-562.15
-737.48
-646.27
-596.4
-589.13
Gross margin %
—
100
100
—
100
-376.05
-1 678.48
Operating margin %
—
-6 429.77
-5 404.35
—
2.86 M
-5 306.04
-24.2 K
EBITDA margin %
—
-5 699.92
-4 780.96
—
2.68 M
-551.28
-22.28 K
Net margin %
—
-2 096.36
-764.54
—
3.72 M
-2 003.58
-12.58 K
Liquidity ratios
Quick ratio
—
—
—
—
—
2.95
9.05
Current ratio
5.02
20.75
7.88
4.52
2.4
3.69
11.44
Inventory turnover
—
—
—
—
—
0.71
0.63
Asset turnover
—
0.01
0.01
0
-0
0.02
0.02
Solvency ratios
Debt to assets ratio
—
0.11
0.15
0.31
0.46
0.3
1.43
Debt to equity ratio
—
0.25
0.26
2.9
-1.21
11.4
25.79
Long term debt to total assets ratio
—
0.1
0.15
0.3
0.46
0.3
1.43
Long term debt to total equity ratio
—
0.25
0.26
2.85
-1.2
11.4
25.79
Per share metrics
Operating cash flow per share
—
-2.03
-0.69
-0.71
-0.83
-0.66
-0.7
EBIT per share
—
-2.03
-0.82
-0.97
-0.97
-0.68
-0.72
EBITDA per share
—
-1.8
-0.73
-0.89
-0.9
-0.07
-0.66
Total debt per share
—
0.77
0.3
0.38
0.54
0.22
1.3
Cash per share
—
5.64
1.47
0.78
0.38
0.32
1.16
Net current asset value per share
—
5.74
1.5
0.81
0.4
0.43
1.58
Tangible book value per share
—
3.06
1.13
0.13
-0.44
0.02
0.29
Working capital per share
—
5.46
1.31
0.63
0.24
0.31
1.02
Book value per share
—
3.06
1.13
0.13
-0.44
0.02
0.29
News
Humacyte, Inc. (HUMA) Q4 2025 Earnings Call Transcript
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates
Humacyte submits marketing application for Symvess in Israel
Humacyte stock rating reiterated at Buy by D. Boral Capital
Humacyte at Barclays Conference: Strategic Insights and Future Plans
Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Humacyte, Inc. (HUMA) Is Considered a Good Investment by Brokers: Is That True?
Humacyte at TD Cowen Conference: Strategic Advances in Vascular Care
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news
Humacyte stock jumps after securing DoD funding for vascular repair tech
DoD allocates funds for bioengineered vascular repair tech in 2026 budget